Specifically, WNT inhibitory factor 1, a secreted WNT antagonist, was found to be downregulated in human cervical cancer tissues, and to be able to inhibit cervical cancer cell proliferation and invasion in vitro and in vivo through inhibition of the WNT/β-catenin pathway [19]. This evidence concerns the gene WIF1 and cervical carcinoma.